Picking Battles in the $5 Trillion Healthcare Market: with David Berry, the Elon Musk of Biotech

Picking Battles in the $5 Trillion Healthcare Market: with David Berry, the Elon Musk of Biotech

From Billion Dollar Moves™ with Sarah Chen-Spellings | Global Venture Capital by Sarah Chen-Spellings

April 30, 2026 · 47 min

About this episode

David Berry discusses building billion-dollar breakthroughs in healthcare and the intersection of mission, science, and capital.

In this episode of Billion Dollar Moves, I sit down with David Berry, Co-Founder and Managing Partner of Averin Capital, for a conversation about building billion-dollar breakthroughs in healthcare. David has founded more than 30 companies, including seven valued over $1B, and has helped shape companies across biotech, AI drug discovery, microbiome therapeutics, agriculture, and health infrastructure. From losing a childhood friend to brain cancer, to asking why the hardest problems are worth pursuing, David shares how mission, science, and capital come together to create venture-scale healthcare companies. For founders, funders, and family offices investing in the future of health, this is a conversation about conviction, ethics, and building for impact at scale. Watch the full conversation and subscribe for more discussions at the intersection of capital, governance, and long-term wealth. 00:00 - Intro: Why go after the biggest problems? 01:12 - Truth vs. belief in science 03:00 - The myth that humans only use 10% of their brains 04:28 - Rethinking cancer and inherited assumptions 05:38 - How big ideas emerge from questioning “truth” 06:30 - Entrepreneur vs. investor: The N of…

People in this episode

Host: Sarah Chen-Spellings

Guest: David Berry

Topics covered

  • healthcare market
  • biotech
  • venture capital
  • drug discovery
  • entrepreneurship
  • impact investing

Keywords

  • healthcare
  • biotech
  • venture capital
  • drug development
  • AI
  • microbiome
  • entrepreneurship
  • impact

Mentioned in this episode

Organizations: Averin Capital, Seres Therapeutics, Valo Health

More episodes of Billion Dollar Moves™ with Sarah Chen-Spellings | Global Venture Capital

Explore listener stats, chart rankings, contacts and more on the Billion Dollar Moves™ with Sarah Chen-Spellings | Global Venture Capital podcast page.